歐化(01711.HK)急漲39%價量齊創逾兩年高 全年虧轉賺1,683萬兼上市以來首次派息
歐化(01711.HK)全年扭虧為盈兼上市以來首次派息,該股今天突破去年7月所創52周高位0.232元,最高見0.335元,為2019年3月以來最高,現造0.285元,急漲39%,一向疏落成交急增至2,061萬股,同創逾兩年高。
歐化主要經營進口傢俬零售與批發及工程項目。公司昨天收市後公布,截至3月止全年業績扭虧轉賺1,683萬元(上年蝕1,163萬元),每股盈利2.1仙,末期股息0.63仙,為2018年初上市以來首次派息。期內,營業額按年升逾7%至2.35億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.